For the year ending 2025-12-31, EFX had $10,900K increase in cash & cash equivalents over the period. $1,134,300K in free cash flow.
| Cash Flow | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Consolidated net income | 664,300 | 607,300 | 551,700 | 700,200 |
| Depreciation and amortization | 726,900 | 680,600 | 619,800 | 568,600 |
| Stock-based compensation expense | 78,400 | 81,600 | 71,800 | 62,600 |
| Deferred income taxes | 30,200 | -66,900 | -70,200 | 88,100 |
| Gain on fair market value adjustment and gain on sale of equity investments | - | 0 | 13,800 | 36,800 |
| (gain) on sale of asset | - | - | 0 | 0 |
| (gain) on divestiture | - | - | 0 | 0 |
| Gain on fair market value adjustment and gain on sale of equity investments | 1,200 | - | - | - |
| Accounts receivable, net | 40,900 | 66,300 | 23,300 | 138,600 |
| Other assets, current and long-term | -42,600 | 29,500 | 13,000 | 22,400 |
| Current and long-term liabilities, excluding debt | 115,400 | 117,700 | -6,200 | -464,600 |
| Cash provided by operating activities | 1,615,700 | 1,324,500 | 1,116,800 | 757,100 |
| Capital expenditures | 481,400 | 511,500 | 601,300 | 624,500 |
| Acquisitions, net of cash acquired | 74,100 | 0 | 283,800 | 433,800 |
| Cash received from sale of asset | - | - | 0 | 0 |
| Cash received from divestitures | 1,200 | 0 | 6,900 | 98,800 |
| Investment in unconsolidated affiliates, net | - | - | - | 0 |
| Cash used in investing activities | -554,300 | -511,500 | -878,200 | -959,500 |
| Net short-term borrowings (payments) | 474,700 | 91,200 | -371,200 | 242,200 |
| Payments on long-term debt | 400,200 | 1,445,600 | 579,300 | 500,000 |
| Proceeds from issuance of long-term debt | 1,700 | 649,800 | 872,900 | 749,300 |
| Treasury stock purchases | 927,500 | - | 0 | 0 |
| Dividends paid to equifax shareholders | 232,800 | 193,200 | 191,800 | 191,100 |
| Distributions paid to noncontrolling interests | 6,100 | 4,600 | 45,600 | 3,100 |
| Proceeds from exercise of stock options and employee stock purchase plan | 46,400 | 78,200 | 32,300 | 16,900 |
| Payment of taxes related to settlement of equity awards | 15,000 | 16,800 | 17,300 | 33,900 |
| Purchase of redeemable noncontrolling interests | 900 | 0 | 0 | 400 |
| Debt issuance costs | 0 | 5,400 | 6,200 | 6,200 |
| Other | - | - | - | 0 |
| Cash used in financing activities | -1,059,700 | -846,400 | -306,200 | 273,700 |
| Effect of foreign currency exchange rates on cash and cash equivalents | 9,200 | -13,500 | -800 | -10,800 |
| Increase (decrease) in cash and cash equivalents | 10,900 | -46,900 | -68,400 | 60,500 |
| Cash and cash equivalents, beginning of period | 169,900 | 216,800 | 285,200 | 224,700 |
| Cash and cash equivalents, end of period | 180,800 | 169,900 | 216,800 | 285,200 |
EQUIFAX INC (EFX)
EQUIFAX INC (EFX)